Additionally, therapeutic interventions, such as those that increase TIGIT-expressing T-cell numbers, which may enhance total TIGIT levels within GBM, may be more suitable for detection of 89Zr-αTIGIT via immunoPET. The gene discussed is TIGIT; the disease is glioblastoma.